No Data
No Data
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
Maibo Pharmaceutical appoints Jialin Cen as non-executive director B.
Mycopharmaceuticals-B (02181) announced that Mr. Shen Jialin will be appointed as a non-executive director from July 10, 2024; Dr. Tao Qian will be appointed as an independent non-executive director; Dr. Qian Weizhu, the current non-executive director of the company, will be transferred to the executive director position and appointed as the vice president of the company; and Mr. Li Yunfeng will be appointed as the vice president of the company and no longer serve as the chief financial officer.
Milestone Pharmaceuticals-B (02181.HK) appoints Janice Shan as non-executive director.
On July 10th, Gelonhui announced that starting from July 10th, 2024: (i) Mr. Cen Jialin will be appointed as a non-executive director; (ii) Dr. Tao Qian will be appointed as an independent non-executive director; (iii) Dr. Qian Weizhu, the current non-executive director of the company, will be transferred to the position of executive director and will be appointed as the company's vice president; and (iv) Mr. Li Yunfeng will be appointed as the company's vice president and will no longer serve as the company's chief financial officer.
Express News | Mabpharm Ltd - Li Yunfeng Will No Longer Hold Position of CFO
Express News | Mabpharm Ltd - Li Yunfeng Appointed as a Vice President
Express News | Mabpharm Ltd - Qian Weizhu Re-Designated as Executive Director
No Data